Elsewhere, an Israeli study published on Saturday also found that a three-dose course of the Pfizer-BioNTech vaccine provided significant protection against the omicron variant.
London: Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with Covid-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by the Oxford Clinical Trials Research Unit (OCTRU), will enrol up […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.